Second primary malignancies in patients with Merkel cell carcinoma: a national database study

International Journal of DermatologyEarly View Correspondence Second primary malignancies in patients with Merkel cell carcinoma: a national database study Vignesh Ramachandran MD, Corresponding Author Vignesh Ramachandran MD [email protected] orcid.org/0000-0002-4958-2182 Department of Dermatology, New York University, New York, NY, USASearch for more papers by this authorAsad Loya MD, Asad Loya MD Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USASearch for more papers by this authorDavid M. Ozog MD, David M. Ozog MD Department of Dermatology, Henry Ford Health, Detroit, MI, USASearch for more papers by this authorHenry W. Lim MD, Henry W. Lim MD Department of Dermatology, Henry Ford Health, Detroit, MI, USASearch for more papers by this author Vignesh Ramachandran MD, Corresponding Author Vignesh Ramachandran MD [email protected] orcid.org/0000-0002-4958-2182 Department of Dermatology, New York University, New York, NY, USASearch for more papers by this authorAsad Loya MD, Asad Loya MD Department of Ophthalmology, Baylor College of Medicine, Houston, TX, USASearch for more papers by this authorDavid M. Ozog MD, David M. Ozog MD Department of Dermatology, Henry Ford Health, Detroit, MI, USASearch for more papers by this authorHenry W. Lim MD, Henry W. Lim MD Department of Dermatology, Henry Ford Health, Detroit, MI, USASearch for more papers by this author First published: 07 March 2023 https://doi.org/10.1111/ijd.16638 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Saxena A, Rubens M, Ramamoorthy V, Khan H. Risk of second cancers in merkel cell carcinoma: a meta-analysis of population based cohort studies. J Skin Cancer. 2014; 2014:184245. 2Prommegger R, Ensinger C, Steiner P, Sauper T, Profanter C, Margreiter R. Neuroendocrine tumors and second primary malignancy—a relationship with clinical impact? Anticancer Res. 2004; 24: 1049– 51. 3Erstad DJ, Cusack JC Jr. Mutational analysis of merkel cell carcinoma. Cancers (Basel). 2014; 6(4): 2116– 36. 4Liang E, Brower JV, Rice SR, Buehler DG, Saha S, Kimple RJ. Merkel cell carcinoma analysis of outcomes: a 30-year experience. PLoS One. 2015; 10(6):e0129476. 5Koljonen V, Rantanen M, Sahi H, Mellemkjær L, Hansen BT, Chen T, et al. Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries. Leuk Lymphoma. 2015; 56(12): 3315– 9. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation